BSE filing, BSE: 544759. Summary written from the filing by ALFA Finder's alert engine.
Goldline Pharmaceutical Ltd: key numbers
- Share price
- ₹30.50
- Market cap
- ₹29.28 Cr
- Revenue (annual)
- ₹31.20 Cr
- Net profit (annual)
- ₹4.12 Cr
- P/E (TTM)
- 7.1×Sector 46.1×
- Promoter holding
- 59.54%
- FII holding
- 0.31%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Goldline Pharmaceutical Ltd
All →Goldline Pharmaceutical Other Announcement
Goldline Pharmaceutical submitted a certificate confirming non-applicability of Regulation 74(5) for the quarter ended September 30, 2026, as all shares are in demat form.
Goldline Pharmaceutical Annual General Meeting
Goldline Pharmaceutical Ltd held its 22nd Annual General Meeting on August 29, 2026, where directors and key management presented financial performance and future business outlook.
Goldline Pharmaceutical Promoter Buying
Promoter Swapan Khandelwal increased his stake in Goldline Pharmaceutical Limited by 0.81% through an open market acquisition of 78,000 shares.
Goldline Pharmaceutical Other Announcement
Goldline Pharmaceutical Ltd announced the closure of its Register of Members and Share Transfer Books from August 23 to August 29, 2026, for its AGM.
Goldline Pharmaceutical Annual General Meeting
Goldline Pharmaceutical Limited has issued a notice for its 22nd Annual General Meeting, scheduled for August 29, 2026. The meeting will address financial statements, dividends, and director re-appointments.
Goldline Pharmaceutical Capital Structure Change
Executive Director Mr. Prashant Shrikrishna Karkare acquired 27,000 equity shares of Goldline Pharmaceutical via an open market purchase. This is a non-promoter insider transaction.
Other annual report announcements
All →LWS Knitwear Annual Report
LWS Knitwear files its FY 2025-26 Annual Report, including the 37th AGM notice set for 20 November 2026. No single material transaction is announced.
Punjab Communications Annual Report
Punjab Communications filed its 45th Annual Report for FY 2025-26 with BSE under SEBI LODR Reg 34(1). The report includes audited financials, board report, and 45th AGM notice.
Aban Offshore Annual Report
Aban Offshore filed its Annual Report for FY 2025-26, including the 40th AGM notice for 16 November 2026. The company remains under CIRP with powers suspended.
Vipul Annual Report
Vipul Limited submitted its 2025-26 Annual Report and the notice for its 35th Annual General Meeting, scheduled for November 12, 2026.
Supreme Infrastructure India Annual Report
Supreme Infrastructure India Limited filed its Annual Report for FY 2025-26 with the BSE. The report covers corporate overview, statutory reports, and financial statements.
Krishna Filament Industries Annual Report
Krishna Filament Industries has submitted its 38th Annual Report for the financial year 2025-26 along with the Notice of the Annual General Meeting.